Re: Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

被引：0
|
作者：
van den Bergh, Roderick C. N. [1 ]
Zargar, Homayoun [1 ]
Murphy, Declan G. [1 ]
机构：
[1] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
EUROPEAN UROLOGY | 2016年 / 69卷 / 05期
关键词：
RADICAL PROSTATECTOMY;
D O I：
10.1016/j.eururo.2016.02.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：964 / 965
页数：3
相关论文
共 50 条
  • [31] THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Paudel, Roshan
    Madan, Raghav
    Qi, Ji
    Cher, Michael
    Lane, Brian
    George, Arvin
    Semerjian, Alice
    Ginsburg, Kevin
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E745 - E745
  • [32] PATHOLOGIC OUTCOMES IN MEN MEETING CRITERIA FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER
    Conti, Simon
    Dall'Era, Marc
    Fradet, Vincent
    Cowan, Janet E.
    Simko, Jeffery
    Carroll, Peter R.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 60 - 60
  • [33] Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer
    Tosoian, Jeffrey J.
    Mamawala, Mufaddal
    Epstein, Jonathan I.
    Landis, Patricia
    Wolf, Sacha
    Trock, Bruce J.
    Carter, H. Ballentine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (30) : 3379 - +
  • [34] Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer
    Gandaglia, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2016, 69 (02) : 370 - 370
  • [35] Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2016, 196 (02): : 412 - 413
  • [36] Re: Active Surveillance for Men with Intermediate Risk Prostate Cancer
    Koehne, Elizabeth L.
    Flanigan, Robert C.
    [J]. EUROPEAN UROLOGY, 2021, 79 (06) : 892 - 893
  • [37] Are men with favorable intermediate-risk prostate cancer candidates for active surveillance?
    Raldow, Ann Caroline
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony Victor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [38] Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
    Tosoian, J. J.
    Patel, H. D.
    Mamawala, M.
    Landis, P.
    Wolf, S.
    Elliott, D. J.
    Epstein, J. I.
    Carter, H. B.
    Ross, A. E.
    Sokoll, L. J.
    Pavlovich, C. P.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (03) : 339 - 342
  • [39] Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
    J J Tosoian
    H D Patel
    M Mamawala
    P Landis
    S Wolf
    D J Elliott
    J I Epstein
    H B Carter
    A E Ross
    L J Sokoll
    C P Pavlovich
    [J]. Prostate Cancer and Prostatic Diseases, 2017, 20 : 339 - 342
  • [40] PREVIOUSLY DEVELOPED SYSTEMS-BASED BIOPSY MODEL (PROSTATE PX plus ) IDENTIFIES FAVORABLE-RISK PROSTATE CANCER FOR MEN ENROLLED IN AN ACTIVE SURVEILLANCE PROGRAM
    Donovan, Michael
    Khan, Faisal
    Powell, Douglas
    Fernandez, Gerardo
    Feliz, Aaron
    Hansen, Thomas
    Bernardino, Lourdes
    Capodieci, Paola
    Bayer-Zubek, Valentina
    Liu, Quihua
    Vance, Rav
    Klotz, Laurence
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E517 - E518
12345